Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 217 - 224 of 12011 results
The Founder of Harvey Says a Massive Shift Is Coming to the Legal Profession
March 13, 2025| News
Trouble at the USPTO—Part II: Bracing for Impact
March 13, 2025| News
FDA’s Backup LDT Enforcement Method: Specimen Collection Kits
March 13, 2025| Blog| Viewpoint
Mintz on Air: Practical Policies - Bridging the State and Federal DEI Chasm
March 11, 2025| Podcast| Viewpoint
Key Employment Law Considerations for Canadian Businesses Impacted by Tariffs
March 11, 2025| Blog| Viewpoint
Bond Dealers Predict Changes to Tax Exemption Amid 'Volatile' Tax Talks
March 11, 2025| News
Health Law Diagnosed – Understanding the New Massachusetts Health Care Market Review Law
March 11, 2025| Podcast| Viewpoint
The State of the Funding Market for AI Companies: A 2024 - 2025 Outlook
March 10, 2025| Blog| Viewpoint
News & Press Releases
Mintz advised The Eagle Leasing Company, a leading provider of portable storage containers, ground level offices, semi-trailers, and mobile office solutions, in its acquisition by Rent-A-Container (RAC), a portfolio company of Kinderhook Industries, LLC.
Mintz’s Life Sciences practice has been shortlisted in multiple categories for the 2025 LMG Life Sciences Americas Awards. The winners will be announced at an awards ceremony in New York on September 4. In the United States, Mintz was shortlisted in the “Venture Capital Firm of the Year” category. In Canada, Mintz was shortlisted in the “Financial & Corporate Firm of the Year” and “Patent Strategy Firm of the Year” categories.
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Events
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|